Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Thymopentin in Patients After Curative Resection of Small

NCT00460681 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT00460681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Thymopentin in Patients After Curative Resection of Small
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2007
Completion date
February 29, 2012
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma